# FDA Inspection 1041621 - Biomat USA Inc - February 02, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/76bcbf1a-9767-4c8d-9bdf-8d470c5a72d5
Source feed: FDA_Inspections

> FDA Inspection 1041621 for Biomat USA Inc on February 02, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041621
- Company Name: Biomat USA Inc
- Inspection Date: 2018-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191657 - 2022-11-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bab380ef-d7c8-4802-892d-674da1ce5c53)
- [FDA Inspection 1191657 - 2022-11-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8957544a-a8ac-4db0-a127-14daf2ef508f)
- [FDA Inspection 954118 - 2015-12-11](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/488aaac4-7e55-4d14-839f-bbee5e938713)
- [FDA Inspection 880733 - 2014-05-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/111f34bb-f60b-4422-b1a9-968b70af940f)
- [FDA Inspection 769975 - 2012-02-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/32daae68-eeb4-492a-afb6-71cb6af8680d)

Company: https://www.keypedia.com/companies/biomat-usa-inc/997257f2-f7f9-4d4c-b193-1b3b791381c5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d